DrugPatentWatch Database Preview
RITUXAN Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Summary for Tradename: RITUXAN
| Patents: | 750 |
| Applicants: | 2 |
| BLAs: | 2 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for RITUXAN |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for RITUXAN |
Recent Clinical Trials for RITUXAN
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| AstraZeneca | Phase 2 |
| University of California, San Francisco | Phase 2 |
| JDP Therapeutics, Inc. | Phase 2 |
Recent Litigation for RITUXAN
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD. | 2019-07-12 |
| CELGENE CORPORATION v. APOTEX INC. | 2019-06-19 |
| Genentech, Inc. v. Pfizer Inc. | 2019-04-05 |
PTAB Litigation
| Petitioner | Date |
|---|---|
| Celltrion, Inc. | 2018-05-04 |
| Apotex Inc. | 2018-02-23 |
| Forty Seven, Inc. | 2018-01-08 |
Pharmacology for RITUXAN
| Mechanism of Action | CD20-directed Antibody Interactions |
Patent Text Search: US Patents for RITUXAN
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | RITUXAN | rituximab | VIAL | 103705 | 001 | 1997-11-26 | Start Trial | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION (Seoul, KR) | 2032-09-12 | RX | search | |
| Genentech | RITUXAN | rituximab | VIAL | 103705 | 001 | 1997-11-26 | Start Trial | Pharmacyclics LLC (Sunnyvale, CA) | 2030-06-03 | RX | search | |
| Genentech | RITUXAN | rituximab | VIAL | 103705 | 001 | 1997-11-26 | Start Trial | Array BioPharma Inc. (Boulder, CO) | 2028-10-22 | RX | search | |
| Genentech | RITUXAN | rituximab | VIAL | 103705 | 001 | 1997-11-26 | Start Trial | SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) | 2033-03-11 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for RITUXAN
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 5175336 | Start Trial |
| Mexico | 2011000758 | Start Trial |
| China | 101695574 | Start Trial |
| Japan | 6061469 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for RITUXAN
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C201730059 | Spain | Start Trial | PRODUCT NAME: INOTUZUMAB OZOGAMICINA; NATIONAL AUTHORISATION NUMBER: EU/1/17/1200; DATE OF AUTHORISATION: 20170629; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1200; DATE OF FIRST AUTHORISATION IN EEA: 20170629 |
| 00140 | Estonia | Start Trial | |
| 300844 | Netherlands | Start Trial | PRODUCT NAME: IBRUTINIB, OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT ERVAN; REGISTRATION NO/DATE: EU/1/14/945 - C(2016)3293 20160530 |
| 2017/054 | Ireland | Start Trial | PRODUCT NAME: INOTUZUMAB OZOGAMICIN; REGISTRATION NO/DATE: EU/1/17/1200/001 20170629 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
